Table 2 Expression analysis of fibrosis mediators in the dextran sodium sulfate model
From: Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis
WT | Pre-Tx Co | Isotype Co | Tl1a Ab—20 mg kg −1 | ||||
---|---|---|---|---|---|---|---|
% β-Actin | % β-Actin | % β-Actin | % β-Actin | P vs. | |||
n =6 | n =5 | n =5 | n =5 | WT | Pre-Tx | Isotype | |
col1a1 | 0.54±0.45 | 0.55±0.36 | 0.67±0.45 | 0.30±0.17 | NS | NS | NS |
col1a2 | 0.67±0.26 | 1.20±0.94 | 1.19±0.93 | 0.63±0.31 | NS | NS | NS |
col3a1 | 35.79±10.95 | 38.64±18.02 | 35.18±9.74 | 23.28±3.47 | 0.044 | NS | 0.036 |
col4a1 | 2.60±1.08 | 2.62±1.37 | 2.70±0.54 | 1.83±0.10 | NS | NS | 0.010 |
Tgfβ1 | 0.21±0.06 | 0.38±0.15 | 0.43±0.03 | 0.22±0.04 | NS | 0.041 | 6.943E-05 |
Ctgf | 0.97±0.27 | 1.1±0.32 | 1.14±0.36 | 0.84±0.21 | NS | NS | NS |
Igf1 | 0.48±0.18 | 0.85±0.63 | 1.09±0.52 | 0.65±0.28 | NS | NS | NS |
Pten | 0.004±0.003 | 0.008±0.004 | 0.012±0.003 | 0.008±0.002 | NS | NS | NS |
Il31Ra | 3.13±0.65 | 2.56±0.61 | 2.67±0.97 | 2.69±0.31 | 0.020 | NS | 0.046 |
Mmp2 | 0.52±016 | 0.60±0.29 | 1.21±0.38 | 0.52±0.25 | NS | NS | 0.007 |
Mmp3 | 0.03±0.015 | 2.07±3.70 | 1.91±0.10 | 0.42±0.27 | 0.003 | NS | 1.48E-05 |
Mmp13 | 0.05±0.011 | 0.61±1.07 | 1.02±0.21 | 0.21±0.15 | 0.014 | NS | 0.0003 |
Timp1 | 0.04±0.024 | 0.32±0.37 | 0.33±0.06 | 0.15±0.07 | 0.003 | NS | 0.004 |
Timp2 | 1.02±0.32 | 0.88±0.17 | 1.12±0.11 | 0.74±0.14 | NS | NS | 0.005 |